Massachusetts Institute of Technology
Cambridge, Massachusetts, United States
Purpose
to test the concept that targeted release of all trans retinoic acid (ATRA) within a lymph node will imprint memory cells with gut-homing capacity, while avoiding toxicity associated with systemic ATRA exposure
Division
Global Health
Date
November 2016
Region Served
GLOBAL
Committed amount
$2,544,808
Grant topic
Discovery and Translational Sciences, Enterics, Diagnostics, Genomics & Epidemiology
Duration (months)
78
Grantee location
Cambridge, Massachusetts, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.